Biotectix

Hanau, Germany Founded: 2007 • Age: 19 yrs Acquired By Heraeus
Conductive coatings for medical implants and instruments

About Biotectix

Biotectix is a Healthcare company based in Hanau (Germany) founded in 2007 by Chris Silva, Sarah Richardson, Mark Pritchard, and Dave Martin, and was acquired by Heraeus in September 2017. Conductive coatings for medical implants and instruments. Biotectix has raised $3 million across 2 funding rounds from investors including Heraeus, Allied Minds and Ann Arbor SPARK. Its focus areas include Medical Device Outsourcing and Contract Manufacturing.

Company details

Biotectix is developing conductive polymer materials, hydrogels and coatings for electrodes used in implantable and external medical devices and sensors such as pacemakers, cortical probes, cochlear implants, glucose sensors, and deep brain stimulators.. The company claims that the benefits of this technology include improved electrical performance, biocompatibility, and tissue response. The company offers its products to medical device manufacturers. Biotectix is a subsidiary of Allied Minds (London Stock Exchange: ALM)

  • Headquarters Hanau, Germany
  • Founders Chris Silva, Sarah Richardson, Mark Pritchard, Dave Martin
  • Stage Acquired
  • Sectors
    Healthcare
  • Website biotectix.com
  • Social LinkedIn
  • Acquired by Heraeus (Sep 2017)
Key Metrics
  • Total Equity Funding
    $3M (USD)

    in 2 rounds

  • Latest Funding Round
    $3M (USD), Series A

    Sep 2010

  • Investors
    Heraeus

    & 2 more

  • Acquired by
    Heraeus

    (Sep 2017)

Funding Insights of Biotectix

Biotectix has successfully raised a total of $3M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3M
  • Total Rounds 2
  • Last Round Series A β€” $3M
  • Investors Count 2

All 2 funding rounds of Biotectix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2010$3MSeries A––
Feb 2009Seed––
Valuation history

3 investors in total: 3 institutional.

Investors in Biotectix

Biotectix has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Heraeus, Allied Minds and Ann Arbor SPARK.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
US focused seed and early-stage VC firm
2004alliedminds.comBoston, United States
annarborusa.org
Materials for multiple industries are developed by Heraeus.
1851heraeus.comHanau, Germany
Premium access

Investor details for Biotectix

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Biotectix

4 people are tracked at Biotectix (4 in leadership).

NameRoleGroup
Chris Silva
Co-FounderLeadership
Sarah Richardson
Co-FounderLeadership
Mark Pritchard
Co-FounderLeadership
Dave Martin
Co-FounderLeadership
Premium access

Complete people profiles for Biotectix

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Biotectix

4 dated milestones of Biotectix across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Biotectix is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A, of $3.0M.
  4. Exit Acquired by Heraeus.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Biotectix

Biotectix was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Biotectix is headquartered in Hanau, Germany. It is registered at Hanau, Hessen, Germany.

Biotectix is a funded company, having raised a total of $3M across 2 funding rounds to date.

Biotectix is developing conductive polymer materials, hydrogels and coatings for electrodes used in implantable and external medical devices and sensors such as pacemakers, cortical probes, cochlear implants, glucose sensors, and deep brain stimulators.. The company claims that the benefits of this technology include improved electrical performance, biocompatibility, and tissue response. The company offers its products to medical device manufacturers. Biotectix is a subsidiary of Allied Minds (London Stock Exchange: ALM).

Biotectix has 3 investors. Key investors include Heraeus, Allied Minds, and Ann Arbor SPARK.

Yes. Biotectix was acquired by Heraeus in September 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available